Adial Pharmaceuticals US patent, enhancing genetic diagnostic coverage for tailored treatment of alcohol and drug dependencies, including opioid use disorder. Learn more about AD04's potential in addressing a $40 billion U
CHARLOTTESVILLE, Va., Feb. 13, 2024 Adial Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and.
By Chris Wack Adial Pharmaceuticals shares were up 26% to $1.42 after the company was awarded a patent notice of allowance from the U.S. Patent and Trademark.
Lexaria Bioscience (NASDAQ:LEXX – Get Free Report) and Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Analyst Recommendations This is a summary of […]
Short Interest in Adial Pharmaceuticals, Inc (NASDAQ:ADIL) Rises By 11 4% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.